Quote changed by moderator!!! Please read the forum rules!!!Yeah, right--the CoQ10 manufacturers want to make a lot of money by selling huge volumes of CoQ10. So their evil genius plot is to:
1) Study a disease that is so obscure almost no one recognizes its name, and
2) Pay off a respected Peyronie's specialist in Iran to bias his results, because everybody automatically trusts research coming out of Iran, and any research that is done in Iran immediately makes it into the peer-reviewed journals without any serious criticism, because the Iranian Peyronie's research cabal is so powerful.
--------------------------
I don't think supplement manufacturers are any more honest than pharmaceutical companies--though they have only a tiny fraction as much money. (And pharmaceutical companies have already been shown to have deliberately withheld negative results; there is legislation pending on this in the US.) In any case, your criticism that manufacturers may have sponsored and therefore biased the results are quite valid--and they are far more valid in the case of most published studies of pharmaceuticals. Therefore following your logic, we can't believe anything...
...but, after your deep research on the topic (i.e. you read a Wikipedia entry--and those are never biased or incorrect) you choose to seriously question only one clinical, peer-reviewed study.
And you pick one where the financial stakes for the producers are so low that they would have to be idiots to spend any money on deception. Hey, that makes sense!
---------------------
By the way, Safarinejad's study on
Pentox is considered to be the pioneering study on
Pentox and Peyronie's. It was published a year before his CoQ10 study. If I am to doubt his CoQ10 study, then I really have to question his earlier
Pentox study, because I assure you, Sanofi/Aventis Pharmaceuticals have a lot more cash than all the vitamin manufacturers in the world put together--and far greater profit margins, since they are behind a wall of patents.
I'm a little baffled. According to the Library, you provided the link to the CoQ10 study you are questioning--though only to the abstract.
I've read both of the full studies. Point by point, the studies were conducted in an almost-identical fashion; even the layout of the tables is similar.
Overall, the results of the CoQ10 study were more positive than the results of the
Pentox study.
So, if you are going to throw away one of these two oral treatments, I'd throw away the
Pentox first.
So why are you focusing on the CoQ10?